论文部分内容阅读
目的:探讨非小细胞肺肿瘤(NSCLS)患者红细胞输注的临床疗效。方法:分析2011-01-2013-12我院158例已经确诊的NSCLS患者无效输注的发生情况。结果:158例NSCLS患者中,红细胞无效输注有38例(24.05%),且NSCLSⅣ期和输血次数10次以上的患者发生红细胞无效输注在50%以上。结论:红细胞无效输注与患者输血次数和NSCLS分期有关,输血次数愈多和癌症晚期(Ⅳ期),无效输血率也就越高。
Objective: To investigate the clinical efficacy of red blood cell transfusion in patients with non-small cell lung cancer (NSCLS). Methods: The incidence of ineffective infusions in 158 NSCLS patients diagnosed in our hospital from January 2011 to December 2013 was analyzed. Results: Of the 158 patients with NSCLS, 38 patients (24.05%) had ineffective erythrocyte infusion and more than 50% of patients had failed erythrocyte infusion after NSCLS Ⅳ and more than 10 transfusions. CONCLUSION: The invalid transfusion of RBC is related to the number of transfusions and NSCLS staging. The more times of transfusions and the later stage of cancer (stage IV), the higher the rate of invalid transfusion.